Cargando…
Anticancer activity of the iron facilitator LS081
BACKGROUND: Cancer cells have increased levels of transferrin receptor and lower levels of ferritin, an iron deficient phenotype that has led to the use of iron chelators to further deplete cells of iron and limit cancer cell growth. As cancer cells also have increased reactive oxygen species (ROS)...
| Autores principales: | , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3077325/ https://www.ncbi.nlm.nih.gov/pubmed/21453502 http://dx.doi.org/10.1186/1756-9966-30-34 |